GLP-1 receptor agonists appeared to have little or no effect on hospitalization for heart failure, with the exception of AMPLITUDE-O (Efpeglenatide) and Harmony Outcomes (Albiglutide), which showed a statistically significant reduction in HF events. The gene discussed is GLP1R; the disease is hydrops fetalis.